Quantum BioPharma
在场
Quantum BioPharma 在 2 个国家有直接业务。
他们在：
涉及Quantum BioPharma的并购和融资。
- Quantum BioPharma将在Aug 14, 2024将其名称改为Quantum BioPharma。 (公布2024八月14号).
高管
查看带有其 21 名主要高管的组织结构图
Quantum BioPharma 搜索最多的简介
- Zeeshan Saeed, Chief Executive Officer & Executive Co-Chairman oft...
- Anthony Durkacz, Executive Co-Chairman of the Board of Directors
- Adnan Bashir, Director
创建提醒
跟踪 Quantum BioPharma 的高管变动
药店
Quantum BioPharma 拥有 1,837 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Quantum BioPharma 的最新新闻稿
- Press Releases
- FSD Pharma Announces Engagement with Capital Markets Communications Providers and Market Maker :: FSD Pharma Inc. (HUGE)
- FSD Pharma Announces Closing of Lucid Psycheceuticals Acquisition :: FSD Pharma Inc. (HUGE)
- FSD Pharma Inc. Announces Results of the Annual General and Special Meeting of Shareholders – Nominees of the Concerned Shareholders Elected to the Board of Directors :: FSD Pharma Inc. (HUGE)
- FSD Pharma Inc. Appoints a New Independent Director :: FSD Pharma Inc. (HUGE)
- FSD Pharma Inc. Announces Termination of FSD-201 Phase 2 Clinical Trial :: FSD Pharma Inc. (HUGE)
- FSD Pharma Inc. Announces Termination of Chief Executive Officer Dr. Raza Bokhari for Cause :: FSD Pharma Inc. (HUGE)
- FSD Pharma Announces Definitive Agreement to Acquire Lucid Psycheceuticals :: FSD Pharma Inc. (HUGE)
- FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update | FSD Pharma Announces Third Quarter 2020 Financial Results and Provides Corporate Update – FSD Pharma
- FSD Pharma Announces Settlement of Class Action Proceeding | FSD Pharma Announces Settlement of Class Action Proceeding – FSD Pharma
- View more press releases Close
通过电子邮件
